Clariant Pharmaceuticals Private Limited

Clariant Pharmaceuticals Private Limited - trading in Tinsukia, Assam, India. FY 2026 financials & compliance.
CIN U51909AS2010PTC009831 Incorporated 12 March 2010 ROC Guwahati HQ Tinsukia, Assam, India
Active Private Limited Company trading
Data last updated
Revenue · FY 2025
₹2.04 Cr
▼ 5% YoY
Net profit · FY 2025
₹6.81 Lakh
Net margin 3.3%
EBITDA · FY 2025
₹14 Lakh
EBITDA margin 6.9%
Authorised capital
₹4 Lakh
Registered with MCA
Paid-up capital
₹2.1 Lakh
Issued & subscribed
Satisfied charges
₹6 Lakh
No open charges
Company age
16 yrs
Est. 2010
Directors on board
2
As per MCA filings

About Clariant Pharmaceuticals Private Limited

Data last updated:

Clariant Pharmaceuticals Private Limited is a private limited company based in Tinsukia, Assam, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 12 March 2010 and has been in existence for over 16 years.

The company is registered with the Registrar of Companies (ROC), Guwahati, under CIN U51909AS2010PTC009831. Its GSTIN is 18AADCC9205H1ZP (Assam). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹4 Lakh and a paid-up capital of ₹2.1 Lakh. It is led by directors Ataur Rahman and Sajidur Rahman.

Its last annual general meeting (AGM) was held on 23 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Near Nepali Mandir Dr. Nabiullah Road, Tinsukia, Assam, India – 786125.

As per the financials filed for FY 2025, the company reported a revenue of ₹2.04 Cr, a decline of 5% compared to the previous year. For the same year it recorded a net profit of ₹6.81 Lakh (net margin 3.3%) and EBITDA of ₹14 Lakh (EBITDA margin 6.9%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 1% over five years.

As per MCA filings, the company has satisfied charges of ₹6 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Clariant Pharmaceuticals Private Limited
CIN U51909AS2010PTC009831
Registration Number 009831
Incorporation Date 12 March 2010
ROC Guwahati
Listing Status Unlisted
Company Status Active
Date of Last AGM 23 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Near Nepali Mandir Dr. Nabiullah Road, Tinsukia, Assam, India – 786125
  • Industry
    Trading, Wholesale, Other Wholesale
Comprehensive company report
Clariant Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Clariant Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Clariant Pharmaceuticals Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Clariant Pharmaceuticals Private Limited

The main business activity of Clariant Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Clariant Pharmaceuticals Private Limited FY 2025 filings available

Clariant Pharmaceuticals Private Limited reported revenue of ₹2.04 Cr (down 5% YoY) for FY 2025.

Revenue · FY 2025
₹2.04 Cr ▼ 5%
Net profit · FY 2025
₹6.81 Lakh margin 3.3%
EBITDA · FY 2025
₹14 Lakh margin 6.9%

Compounded Annual Growth Rate (CAGR) of Clariant Pharmaceuticals Private Limited

Revenue CAGR growth
1 year
▼ 5%
3 years · compounded
▲ 4%
5 years · compounded
▲ 1%
EBITDA CAGR growth
1 year
▼ 33%
3 years · compounded
▼ 8%
5 years · compounded
▲ 1%

Revenue fell 5% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 1%. EBITDA fell 33% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Clariant Pharmaceuticals Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹14 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹6.81 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Clariant Pharmaceuticals Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin6.9%••••••••••••••••
Net Profit Margin3.3%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Clariant Pharmaceuticals are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Clariant Pharmaceuticals Private Limited

Clariant Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Ataur RahmanDirector12 Mar 201016 Years 7 MonthsCurrent
Sajidur RahmanDirector12 Mar 201016 Years 7 MonthsCurrent

Peer Comparison of Clariant Pharmaceuticals Private Limited

Clariant Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Zebx Pharmaceuticals Private Limited₹2.08 Cr (FY 2025)••••••••492.0%••••Aramane Nagar, Karnataka, India
Enma Pharmaceuticals Private Limited₹2.08 Cr (FY 2025)••••••••8.0%••••Chennai, Tamil Nadu, India
Macromed Pharmaceuticals Private Limited₹2.07 Cr (FY 2020)••••••••-1.0%••••Puducherry, India
Shona Pharmaceuticals Private Limited₹2.07 Cr (FY 2015)••••••••4098650.0%••••Chennai, Tamil Nadu, India
Healthridge Pharmaceuticals Private Limited₹2.05 Cr (FY 2023)••••••••1.0%••••Panchkula, Haryana, India
Clariant Pharmaceuticals Private Limited this company₹2.04 Cr (FY 2025)••••••••-5.0%••••Tinsukia, Assam, India
Stave Pharmaceuticals Private Limited₹2.04 Cr (FY 2025)••••••••20.0%••••Patna, Bihar, India
Vianex Pharmaceuticals Private Limited₹2.03 Cr (FY 2024)••••••••50.0%••••Neyyattinkara, Kerala, India
Pavittar Pharmaceuticals Private Limited₹2.03 Cr (FY 2023)••••••••97.0%••••Chandigarh, India
Clementia Pharmaceuticals Private Limited₹2.02 Cr (FY 2025)••••••••3.0%••••Thane, Maharashtra, India
Vogue Pharmaceuticals Private Limited₹2.02 Cr (FY 2025)••••••••-5.0%••••New Delhi, Delhi, India

Peers are the five companies nearest above and the five nearest below Clariant Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Clariant Pharmaceuticals Private Limited

Clariant Pharmaceuticals Private Limited is audited by Sunil Pankaj & Co. for the financial year 2017.

NameStatusAppointment DateCessation Date
Sunil Pankaj & Co.LockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Clariant Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Clariant Pharmaceuticals Private Limited

Open charges
None
Satisfied charges
₹6 Lakh
Breakdown by lending institutions
State Bank of India₹0.06 Cr
Latest charge details
DateLenderAmountStatus
21 Mar 2012State Bank of India₹6 LakhSatisfied

Total charge records: 1 View all charges

Employees and EPFO Compliance at Clariant Pharmaceuticals Private Limited

Employment history and EPFO contributions of people linked to Clariant Pharmaceuticals.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Clariant Pharmaceuticals Private Limited

Clariant Pharmaceuticals Private Limited has 2 board changes on record since 2010: 2 appointments. The latest: Ataur Rahman was appointed as Director on 12 Mar 2010.

AGM
Clariant Pharmaceuticals Private Limited last Annual general meeting of members was held on 23 Sep 2025 as per latest MCA records.
Filing
Clariant Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Guwahati.
Charges
A charge registered on 21 Mar 2012 via Charge ID 10344027 with State Bank Of India was fully satisfied on 04 Sep 2018.
Charges
A charge with State Bank Of India of Rs. 6.00 Lakh registered on 21 Mar 2012 with Charge ID 10344027 was modified on 27 Jun 2015.
Charges
A charge with State Bank Of India amounted to Rs. 6.00 Lakh with Charge ID 10344027 was registered on 21 Mar 2012.
Appointed
Ataur Rahman was appointed as Director.
Appointed
Sajidur Rahman was appointed as Director.
Incorporation
12 Mar 2010
Clariant Pharmaceuticals Private Limited was registered on 12 Mar 2010 with Roc Guwahati & aged 16 years 7 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Clariant Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Clariant Pharmaceuticals Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Clariant Pharmaceuticals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Clariant Pharmaceuticals Private Limited

Clariant Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
18AADCC9205H1ZPAssamActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Clariant Pharmaceuticals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Clariant Pharmaceuticals Private Limited

Clariant Pharmaceuticals is an active private limited company based in Tinsukia, Assam, India. The company works in wholesale, within the trading industry. It was incorporated on 12 March 2010 (16+ years old) and is registered under CIN U51909AS2010PTC009831.

Clariant Pharmaceuticals reported revenue of ₹2.04 Cr for FY 2025 (down 5% YoY).

Clariant Pharmaceuticals has 2 current directors:

Clariant Pharmaceuticals reported a net profit of ₹6.81 Lakh (net margin 3.3%) and EBITDA of ₹14 Lakh (EBITDA margin 6.9%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Clariant Pharmaceuticals is 4% over three years and 1% over five years. In the latest year (FY 2025) revenue fell 5%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Clariant Pharmaceuticals is 18AADCC9205H1ZP, registered in Assam. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Clariant Pharmaceuticals is U51909AS2010PTC009831. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Clariant Pharmaceuticals was incorporated on 12 March 2010, making it 16+ years old. It is registered with the Registrar of Companies, Guwahati.

The peers of Clariant Pharmaceuticals by revenue are Zebx Pharmaceuticals Private Limited, Enma Pharmaceuticals Private Limited, Macromed Pharmaceuticals Private Limited, Shona Pharmaceuticals Private Limited, Healthridge Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).

Ataur Rahman was appointed as Director on 12 Mar 2010. Sajidur Rahman was appointed as Director on 12 Mar 2010.

The registered office of Clariant Pharmaceuticals is at Near Nepali Mandir Dr. Nabiullah Road, Tinsukia, Assam, India – 786125.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available